Merck KGaA (MKKGY) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Darmstadt, Germany. The current CEO is Belen Garijo Lopez.
MKKGY has IPO date of 2007-11-16, 59,020 full-time employees, listed on the Other OTC, a market capitalization of $59.59B.
Merck KGaA is a German science and technology company founded in 1668 and headquartered in Darmstadt. Operating through three primary segments—Life Science, Healthcare, and Electronics—the company serves academic, pharmaceutical, biotech, and industrial markets globally. The Life Science segment provides laboratory tools, chemicals, equipment, and process development technologies for drug manufacturers, while also offering testing solutions for environmental and nutritional analysis. The Healthcare segment discovers and manufactures prescription drugs and biopharmaceuticals focused on oncology, neurology, immunology, fertility, endocrinology, and other therapeutic areas, alongside injection devices and monitoring software. The Electronics segment supplies advanced materials for semiconductor and display industries, as well as specialized surface solutions for cosmetics and functional applications. Merck KGaA also pursues strategic partnerships and in-licensing agreements to expand its oncology and specialized therapeutic pipelines.
